U.S. OKs new Merck drug for rare skin cancer
626150
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.
205305
Federal health advisers on Wednesday recommended approval of the first new cancer drug in the past decade specifically aimed at treating the most common childhood leukemia.
549819
Merck & Co Inc. won U.S. approval  for a new drug to treat a rare and slow-growing skin cancer  called advanced cutaneous T-cell lymphoma (CTCL), health  officials said on Friday.
432135
The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
39535
Sanofi-Aventis said on Friday that U.S. regulators had approved wider use for its colon cancer drug Eloxatin, lifting shares in the world's third-largest pharmaceuticals group.
105566
A skin patch to treat the dementia suffered by Alzheimerâs patients has gained federal approval, a drug company said.
747218
Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.
669994
US researchers have discovered a new virus they believe may be linked to a rare but extremely lethal type of skin cancer, a study released Thursday said.
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.
410925
An experimental treatment for brain cancer has won approval for commercial use in Switzerland, its London-listed US maker, Northwest Biotherapeutics, Inc., announced on Monday.
411562
The U.S. Food and Drug   Administration said on Monday it had approved Cephalon Inc.'s   drug Fentora to treat pain in certain cancer patients.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
57060
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option yesterday with the approval of a novel drug -- but how much benefit it offers is unclear.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.